Albert Bourla

Albert Bourla

executive United States

Albert Bourla is the CEO of Pfizer, a leading global pharmaceutical company. He gained significant recognition for his leadership during the COVID-19 pandemic, particularly for spearheading the rapid development of the vaccine. Recently, he has indicated Pfizer's focus on oral medications for obesity treatments, acknowledging the company's late entry into the injectable space.

Born on Oct 21, 1961 (64 years old)

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
31,587
Power
889$
Sentiment
5.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Taiwan 1 5.00 0.13% +0% 23,816,775 31,587 $670,000 889$
Totals 1 23,816,775 31,587 $670,000 889$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Switzerland Switzerland: The management, led by Albert Bourla since 2019, has faced criticism for overestimating demand from Covid-19 related businesses. 3

Neue Zürcher Zeitung: Pandemie-Gewinner Pfizer reduziert Schweizer Belegschaft um 40 Prozent

Slovenia Slovenia: Albert Bourla is the CEO of Pfizer who was involved in communications with Ursula von der Leyen during the vaccine procurement process. 5

Delo – major Slovenian daily, est. 1959: Sodišče zavrglo tožbo proti Ursuli von der Leyen zaradi afere Pfizer

Pakistan Pakistan: Albert Bourla, CEO of Pfizer, has supported Trump's nomination for the Nobel Prize based on the Operation Warp Speed initiative. 6

Daily Jang: ٹرمپ کی خواہش پوری ہوگی یا دل ٹوٹے گا؟

Taiwan Taiwan: Trump announced a deal with Pfizer Inc CEO Albert Bourla to cut drug prices in exchange for relief from planned tariffs. 6

Taipei Times – major English newspaper in Taiwan, est. 1999: Trump targets economic deals before midterm votes